Wellington Management Group
AUPH icon

Wellington Management Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Wellington Management Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Sell
44,081
-2,831
-6% -$45.2K ﹤0.01% 1787
2026
Q1 		$695K Sell
46,912
-6,809
-13% -$99.5K ﹤0.01% 1738
2025
Q4 		$857K Buy
53,721
+2,421
+5% +$34.3K ﹤0.01% 1739
2025
Q3 		$567K Sell
51,300
-3,917
-7% -$42.8K ﹤0.01% 1868
2025
Q2 		$468K Buy
55,217
+27
+0% +$216 ﹤0.01% 1830
2025
Q1 		$444K Sell
55,190
-5,561
-9% -$45.1K ﹤0.01% 1835
2024
Q4 		$546K Buy
+60,751
New +$496K ﹤0.01% 1823

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group's AUPH Position: Q2 2026 in Review

Wellington Management Group reduced its Aurinia Pharmaceuticals (AUPH) stake by 6% in Q2 2026, selling an estimated $45.2K and leaving 44,081 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Wellington Management Group first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $857K in Q4 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Wellington Management Group held 44,081 shares of Aurinia Pharmaceuticals worth $748K as of Q2 2026.
  • Wellington Management Group sold 2,831 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $45.2K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1787 holding.
  • Wellington Management Group first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Wellington Management Group's Aurinia Pharmaceuticals position peaked at $857K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.